Search results :

Fluocinonide

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Codes: C05AA11, D07AC08

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10
Headache Headache postmarketing, 2.84% - 3.96% x x x x
Application site pain Application site burn 1.76% - 6.64% x x x x
Application site burn Application site burn 1.76% - 6.64% x x x x
Nasopharyngitis Nasopharyngitis 0.926% - 1.42% x x x x
Nasal congestion Nasal congestion 0% - 1.39% x x x x
Dizziness Dizziness postmarketing x x
Dermatitis Rash postmarketing x x
Dermatitis perioral x x x x x x x
Rash Rash postmarketing x x
Eruption x
Hypersensitivity Hypersensitivity postmarketing x x
Immune system disorder Immune system disorder postmarketing x x
Nervous system disorder Nervous system disorder postmarketing x x
Pain Pain postmarketing x x
Pruritus Pruritus postmarketing x x x x x x x x x
Itch burning x
Swelling Swelling postmarketing x x
Erythema Erythema postmarketing x x
Dry skin Dry skin postmarketing x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing x x
Condition aggravated Condition aggravated postmarketing x x
Skin exfoliation Skin exfoliation postmarketing x x
Skin tightness Skin tightness postmarketing x x
Cushing's syndrome Cushing's syndrome x x
Folliculitis Folliculitis x x x x x x x
Glycosuria Glycosuria x x
Hyperglycaemia Hyperglycaemia x x
Hypertrichosis Hypertrichosis x x x x x x x x
Miliaria Miliaria x x x x x x x
Telangiectasia Telangiectasia x
Application site reaction Application site reaction x x
Skin atrophy Skin atrophy x x x x x x x x
Skin striae Skin striae x x x x x x x x
Dermatitis contact Allergic contact dermatitis x x x x x x x
Leukoderma Leukoderma x x x x x x x
Dermatitis acneiform Acneiform eruption x x x x x x
Cataract subcapsular Cataract subcapsular x
Secondary adrenocortical insufficiency Secondary adrenocortical insufficiency x
Atrophy Atrophy x
Infection Secondary infection x x x x x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Fluocinonide

Side effects:18
Source:FDA Structured Product Label

fluocinonide

Side effects:18
Source:FDA Structured Product Label

FLUOCINONIDE / TIAMOL CREAM 0.05%

Side effects:9
Source:Health Canada

Fluocinonide

Side effects:11
Source:FDA Structured Product Label

FLUOCINONIDE

Side effects:11
Source:FDA Structured Product Label

fluocinonide

Side effects:11
Source:FDA Structured Product Label

FLUOCINONIDE

Side effects:11
Source:FDA Structured Product Label

FLUOCINONIDE

Side effects:11
Source:FDA Structured Product Label

FLUOCINONIDE / VANOS

Side effects:19
Source:FDA

FLUOCINONIDE / VANOS

Side effects:19
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label